Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Huadong Medicine Co Ltd A (000963 CH)
Watchlist
49
Analysis
Health Care
•
China
Huadong Medicine Co., Ltd. wholesales and retails medicines, pharmaceutical preparations, biological products, and medical instruments. Through its subsidiaries, the Company also manufactures antibiotic medicines and biochemical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Thematic (Sector/Industry)
•
07 Aug 2023 13:00
Anti-Corruption in China Healthcare – the Impact and the Outlook
The share prices of China healthcare are now plummeting due to anti-corruption campaign, which will reach a climax in 23H2 (We'll post updates in...
Xinyao (Criss) Wang
Follow
687 Views
Share
bullish
•
Lu Daopei Medical Group
•
27 Feb 2023 13:58
Lu DaoPei Medical Group Pre-IPO - Ramp up in Progress but Looks Promising
Lu Daopei Medical Group (1816743D CH) is looking to raise around US$400m in its upcoming Hong Kong IPO. LDPM has supported its growth through its...
Ethan Aw
Follow
321 Views
Share
bearish
•
Shanghai Haohai Biological Technology
•
10 Feb 2023 08:55
Shanghai Haohai Biological Technology (688366.CH/6826.HK)- Disappointing Earnings and Gloomy Outlook
Continuous M&A fails to bring ideal performance to Haohai. Medical aesthetics is the main growth driver, but Haohai is lack of competitiveness....
Xinyao (Criss) Wang
Follow
305 Views
Share
bullish
•
Huadong Medicine Co Ltd A
•
15 Aug 2022 08:57
Huadong Medicine (000963.CH) 2022H1 - Huadong Is Back on Track. If Shares Pullback, Then Be Long
Huadong released encouraging H1 results.It's back on track. This positive momentum will continue in H2, especially medical cosmetology and...
Xinyao (Criss) Wang
Follow
258 Views
Share
bullish
•
Thematic (Sector/Industry)
•
14 Aug 2022 09:29
China Healthcare Weekly (Aug.12)-AI Drug Discovery, License-In Mode Valuation, Pet Medical Equipment
AI drug discovery is far from meeting the current investment level and expectations. The success of license-in mode must be based on appropriate...
Xinyao (Criss) Wang
Follow
312 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x